Status:
NOT_YET_RECRUITING
Lidocaine, Paracetamol, and Dexmedetomidine for Rocuronium Injection Pain
Lead Sponsor:
Baskent University
Conditions:
Propofol Injection Pain
Rocuronium Injection Pain
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Propofol and rocuronium may cause pain during intravenous injection. Various pharmacological agents are used to reduce the incidence and severity of injection pain. Among the most commonly used agents...
Detailed Description
General anesthesia induction is initiated with propofol, and after loss of consciousness is achieved, rocuronium is administered to provide muscle relaxation. Propofol and rocuronium may cause pain du...
Eligibility Criteria
Inclusion
- Patients who will receive propofol and rocuronium 18 - 65 years No psychiatric disorders Elective surgery Those who accept the research No history of allergy to any of the drugs used in the study Patients in American Society of Anesthesiologists (ASA) I and II class
Exclusion
- Patients with chronic pain syndromes Patients with difficult intravenous access Patients with advanced heart block or heart failure Patients with uncontrolled hypertension (Systolic blood pressure \>160 mmHg)
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT07169227
Start Date
September 1 2025
End Date
October 1 2025
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baskent University
Adana, Adana, Turkey (Türkiye)